Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T19:08:34.094Z Has data issue: false hasContentIssue false
  • English
  • Français

HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey

Published online by Cambridge University Press:  19 October 2009

R. J. Brindle ,
R. P. Eglin ,
A. J. Parsons ,
A. V. S. Hill  and
J. B. Selkon
R. J. Brindle
Affiliation:
Public Health Laboratory, John Radcliffe Hospital, Oxford OX3 9DU
R. P. Eglin
Affiliation:
Public Health Laboratory, John Radcliffe Hospital, Oxford OX3 9DU
A. J. Parsons
Affiliation:
Public Health Laboratory, John Radcliffe Hospital, Oxford OX3 9DU
A. V. S. Hill
Affiliation:
Molecular Haematology Unit, John Radcliffe Hospital, Oxford OX3 9DU
J. B. Selkon
Affiliation:
Public Health Laboratory, John Radcliffe Hospital, Oxford OX3 9DU
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Blood samples from 13 locations in the Pacific and South-East Asia were tested for evidence of infection with human T-cell lymphotropic virus type-1 (HTLV-1), human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis delta virus (HDV). No samples were positive for antibody to HIV-1. Antibodies to HTLV-1 were found in samples from five locations, the maximum prevalence being 19%, in Vanuatu. Serological markers of HBV infection were found in all locations, the maximal prevalence being 88%, in Majuro, Micronesia. Antibodies to HDV in HBsAg positive sera were found in six locations with a maximum prevalence of 81% in Kiribati.

Type
Research Article
Information
Epidemiology & Infection , Volume 100 , Issue 1 , February 1988 , pp. 153 - 156
Copyright
Copyright © Cambridge University Press 1988

References

REFERENCES

Aoki, T., Miyakosh, H., Koide, H.Yoshida, T., Ishikawa, H., Susisaki, Y., Mizukoshi, M., Tamura, K., Misawa, H., Hamada, C., Ting, R. C., Robert-Guroff, M. & Gallo, R. (1985). Seroepidemiology of HTLV-1 in residents of Nigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme linked immunosorbent assay. International Journal of Cancer 35, 301–306.CrossRefGoogle Scholar
Dimitrakakis, M., Crowe, S.& Gust, I. D. (1986). Prevalence of Delta infection in the Western Pacific region. Journal of Medical Virology 18, 335–339.CrossRefGoogle ScholarPubMed
Gessain, A., Barin, R., Vernant, J. C., Gout, O., Maurs, L., Calender, A.& De Thé, G. (1985). Antibodies to HTLV-l in patients with tropical spastic paraparesis. Lancet ii, 407–409.CrossRefGoogle Scholar
Gust, I. D., Lehmann, N. I.& Dimitrakakis, M. (1979). A seroepidemiologic study of infection with HAV and HBV in five Pacific islands. American Journal of Epidemiology 110, 237–242.CrossRefGoogle ScholarPubMed
Gust, I. D. (1984). Epidemiology of viral hepatitis. In Viral Hepatitis and Liver Disease (Ed. Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H.), pp. 415–421. Orlando: Grune and Stratton.Google Scholar
Hadler, S. C., De Monzon, M., Ponzetto, A., Anzola, E., Rivero, D., Mondolfi, A., Brach, A., Francis, D. P., Gerber, M. A., Thung, S., Gerin, J., Maynard, J. E., Popper, H. & Purcell, R. H. (1984). An epidemic of severe hepatitis due to delta virus infection in Yucpa Indians of Venezuela. Annals of Internal Medicine 100, 339–344.CrossRefGoogle ScholarPubMed
Hawkes, R. A., Boughton, C. R., Ferguson, V. & Vale, T. G. (1981). The seroepidemiology of hepatitis in Papua New Guinea. II. Long-term study of hepatitis B. American Journal of Epidemiology 114, 563–573.CrossRefGoogle ScholarPubMed
Hinuma, Y., Chosa, T., Komoda, H., Mori, I., Suzuki, M., Tajima, K., Pan, I. H. & Lee, M. (1983). Sporadic retrovirus (ATLV)-seropositive individuals outside Japan. Lancet i, 824–825.CrossRefGoogle Scholar
Ishida, T., Yamamoto, K., Omoto, K., Iwanasa, M., Osato, T. & Hinuma, Y. (1985). Prevalence of a human retrovirus in native Japanese: evidence for a possible ancient origin. Journal of Infection 11, 153–157.CrossRefGoogle ScholarPubMed
Kuo, T., Chan, H. L., Su, I. J., Eimoto, T., Maeda, Y., Kikuchi, M., Chen, M. J., Kuan, Y. Z., Chen, W. J., Sun, C. F., Sum, L. Y., Chen, J. F. & Takefhita, M. (1985). Serological survey of antibodies to the adult T-cell leukaemia virus associated antigen (HTLV-A) in Taiwan. International Journal of Cancer 36, 345–348.CrossRefGoogle Scholar
Lingao, A. L., Domingo, E. O., West, S., Reyes, C. M., Gasmen, S., Viterbo, G., Tiu, E. & Lansans, M. A. (1986). The seroepidemiology of hepatitis B virus in the Philippines. American Journal of Epidemiology 123, 473–479.CrossRefGoogle ScholarPubMed
Ponzetto, A., Forzani, B., Parravicini, P. P., Hele, C., Azanetti, A. & Rizzetto, M. (1985). Epidemiology of hepatitis delta virus (HDV) infection. European Journal of Epidemiology 1, 257–263.CrossRefGoogle ScholarPubMed
Rodgers-Johnson, P., Gasdusek, D. C., Morgan, O. C., Zaninovic, V., Sarn, P. S. & Graham, D. S. (1985). HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet ii, 1247–1248.CrossRefGoogle Scholar
Wong, D. C., Purcell, R. H. & Rosen, L. (1979). The prevalence of antibody to HAV and HBV in selected populations in the South Pacific. American Journal of Epidemiology 110, 227–236.CrossRefGoogle ScholarPubMed
Zaninovic, V. (1986). Spastic paraparesis: a possible sexually transmitted viral myeloneuropathy. Lancet ii, 697.CrossRefGoogle Scholar